Medicover AB
OTC:MCVEF
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| SE |
|
Medicover AB
STO:MCOV B
|
31.9B SEK |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
99.7B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
77.7B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
65.2B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.8B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
24B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.5B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
23B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.1B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD |
Loading...
|
Market Distribution
| Min | -855 316.7% |
| 30th Percentile | 30.8% |
| Median | 44.8% |
| 70th Percentile | 66% |
| Max | 113 764.6% |
Other Profitability Ratios
Medicover AB
Glance View
Medicover AB, founded in 1995, is a prominent healthcare and diagnostic service provider, chiefly operating across Europe and India. The company, based out of Sweden, has carved a niche by offering a broad range of healthcare services, focusing on accessible and premium quality care. Medicover’s structure is multifaceted—comprising two main divisions: Healthcare Services and Diagnostic Services. Their healthcare division administers preventative and primary care services through outpatient clinics, as well as specialist hospital care, emphasizing a holistic approach to patient care. Meanwhile, the Diagnostic Services division performs a vital role, supplying an extensive array of laboratory and imaging services. This dual-pronged business model ensures a steady stream of revenue, bolstering Medicover’s position in the competitive healthcare landscape. The way Medicover makes money is intricately tied to its wide-reaching network and comprehensive service offerings. Revenues are primarily derived from the fees for healthcare and diagnostic services provided directly to patients and through contracts with insurance companies and corporate clients, who seek Medicover’s expertise in employee health management. In navigating the healthcare sector, Medicover leverages its robust technological infrastructure to optimize service delivery and operational efficiency, ensuring patient satisfaction while maintaining cost-effectiveness. By continuously expanding its geographical footprint and diversifying its service portfolio, Medicover is adept at adapting to evolving market demands, thus securing its long-term financial sustainability and reinforcing its commitment to delivering value-driven healthcare solutions.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Medicover AB is 23%, which is above its 3-year median of 21.4%.
Over the last 3 years, Medicover AB’s Gross Margin has decreased from 24.3% to 23%. During this period, it reached a low of 20.5% on Mar 31, 2024 and a high of 24.3% on Sep 30, 2022.